Home › Acute Lymphoblastic Leukemia › California › Baldwin Park
Pag-aaral pangklinika para sa Acute Lymphoblastic Leukemia sa Baldwin Park, CA
Isang pag-aaral para sa Acute Lymphoblastic Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Baldwin Park. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
Nagre-recruitPhase 2
- City of Hope Cancer Center (Data collection AND Specimen Analysis), Duarte · 4 mi ang layo
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Nagre-recruitPhase 1/2
- Research Site, Duarte · 4 mi ang layo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- City of Hope, Duarte · 4 mi ang layo
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Study of Revumenib and Mezigdomide in People With Leukemia
Nagre-recruitPhase 1/2
- City of Hope Cancer Center (Data collection only), Duarte · 4 mi ang layo
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Nagre-recruitObservasyonal na pag-aaral
- City of Hope Comprehensive Cancer Center, Duarte · 4 mi ang layo
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
Nagre-recruitPhase 3
- Ascentage Investigative Site #1062, Duarte · 4 mi ang layo
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched Related Donor Hematopoietic Cell Transplant for the Treatment of Patients With High-Risk Acute Lymphoblastic Leukemia
Nagre-recruitMaagang Phase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Nagre-recruitPhase 2
- City of Hope, Duarte · 4 mi ang layo
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- City of Hope Medical Center, Duarte · 4 mi ang layo
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Nagre-recruitPhase 1
- City of Hope Medical Center, Duarte · 4 mi ang layo
Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Nagre-recruitPhase 2
- City of Hope Medical Center, Duarte · 4 mi ang layo
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Nagre-recruitPhase 1
- City of Hope, Duarte · 4 mi ang layo
Pag-aaral para sa Acute Lymphoblastic Leukemia sa ibang lungsod
- Houston, TX28 pag-aaral
- New York City, NY24 pag-aaral
- Seattle, WA21 pag-aaral
- Chicago, IL19 pag-aaral
- Atlanta, GA19 pag-aaral
- Memphis, TN16 pag-aaral
- Philadelphia, PA16 pag-aaral
- Washington, DC16 pag-aaral
- Boston, MA15 pag-aaral
- Los Angeles, CA14 pag-aaral
- Durham, NC13 pag-aaral
- Mountain View, CA13 pag-aaral
Iba pang pag-aaral sa Baldwin Park
- Kanser sa Suso45 pag-aaral
- Acute Myeloid Leukemia40 pag-aaral
- Colorectal Cancer38 pag-aaral
- Non-Small Cell Lung Cancer36 pag-aaral
- Kanser (lahat ng uri)33 pag-aaral
- Kanser sa Prostate30 pag-aaral
- Metastatic Cancer30 pag-aaral
- Myelodysplastic Syndromes26 pag-aaral
- Kanser sa Ovary25 pag-aaral
- Kanser sa Baga24 pag-aaral
- Multiple Myeloma23 pag-aaral
- Kanser sa Tiyan22 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.